Ultimovacs ASA (Norway) Price on February 5, 2024
| ULTI Stock | NOK 2.55 0.08 3.24% |
If you're considering investing in Ultimovacs Stock, it is important to understand the factors that can impact its price. As of today, the current price of Ultimovacs ASA stands at 2.55, as last reported on the 11th of December 2024, with the highest price reaching 2.84 and the lowest price hitting 2.40 during the day. Ultimovacs ASA appears to be dangerous, given 3 months investment horizon. Ultimovacs ASA owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.1, which indicates the firm had a 0.1% return per unit of risk over the last 3 months. By inspecting Ultimovacs ASA's technical indicators, you can evaluate if the expected return of 0.61% is justified by implied risk. Please review Ultimovacs ASA's Coefficient Of Variation of 2375.09, semi deviation of 5.03, and Risk Adjusted Performance of 0.0393 to confirm if our risk estimates are consistent with your expectations.
Ultimovacs Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Ultimovacs |
Sharpe Ratio = 0.1022
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ULTI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.94 actual daily | 52 52% of assets are less volatile |
Expected Return
| 0.61 actual daily | 12 88% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 8 92% of assets perform better |
Based on monthly moving average Ultimovacs ASA is performing at about 8% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Ultimovacs ASA by adding it to a well-diversified portfolio.
Ultimovacs ASA Valuation on February 5, 2024
It is possible to determine the worth of Ultimovacs ASA on a given historical date. On February 5, 2024 Ultimovacs was worth 145.8 at the beginning of the trading date compared to the closed value of 144.2. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Ultimovacs ASA stock. Still, in general, we apply an absolute valuation method to find Ultimovacs ASA's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Ultimovacs ASA where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Ultimovacs ASA's related companies.
| Open | High | Low | Close | Volume | |
| 139.40 | 141.20 | 137.40 | 140.40 | 48,088 | |
02/05/2024 | 145.80 | 150.80 | 141.80 | 144.20 | 336,226 |
| 145.00 | 145.00 | 135.00 | 136.40 | 212,202 |
| Backtest Ultimovacs ASA | | | Ultimovacs ASA History | | | Ultimovacs ASA Valuation | Previous | Next |
Ultimovacs ASA Trading Date Momentum on February 5, 2024
| On February 06 2024 Ultimovacs ASA was traded for 136.40 at the closing time. The highest price during the trading period was 145.00 and the lowest recorded bid was listed for 135.00 . The volume for the day was 212.2 K. This history from February 6, 2024 contributed to the next trading day price decline. The trading price change to the next closing price was 5.41% . The trading price change to the current price is 3.88% . |
Ultimovacs ASA Fundamentals Correlations and Trends
By evaluating Ultimovacs ASA's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Ultimovacs ASA's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Ultimovacs financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Ultimovacs ASA Stock history
Ultimovacs ASA investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Ultimovacs is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Ultimovacs ASA will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Ultimovacs ASA stock prices may prove useful in developing a viable investing in Ultimovacs ASA
Ultimovacs ASA, a pharmaceutical company, develops immunotherapies for various cancers. The company was incorporated in 2011 and is headquartered in Oslo, Norway. ULTIMOVACS ASA is traded on Oslo Stock Exchange in Norway.
Ultimovacs ASA Stock Technical Analysis
Ultimovacs ASA technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Ultimovacs ASA Period Price Range
Low | December 11, 2024
| High |
0.00 | 0.00 |
Ultimovacs ASA cannot be verified against its exchange. Please verify the symbol is currently traded on Oslo Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Ultimovacs ASA December 11, 2024 Market Strength
Market strength indicators help investors to evaluate how Ultimovacs ASA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Ultimovacs ASA shares will generate the highest return on investment. By undertsting and applying Ultimovacs ASA stock market strength indicators, traders can identify Ultimovacs ASA entry and exit signals to maximize returns
Ultimovacs ASA Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Ultimovacs ASA's price direction in advance. Along with the technical and fundamental analysis of Ultimovacs Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Ultimovacs to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0393 | |||
| Jensen Alpha | 0.3624 | |||
| Total Risk Alpha | (0.76) | |||
| Sortino Ratio | 0.0267 | |||
| Treynor Ratio | (0.30) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Ultimovacs Stock
Ultimovacs ASA financial ratios help investors to determine whether Ultimovacs Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ultimovacs with respect to the benefits of owning Ultimovacs ASA security.